HCW Biologics (HCWB) Total Debt (2022 - 2025)
Historic Total Debt for HCW Biologics (HCWB) over the last 4 years, with Q3 2025 value amounting to $6.8 million.
- HCW Biologics' Total Debt rose 736.41% to $6.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $6.8 million, marking a year-over-year increase of 736.41%. This contributed to the annual value of $6.3 million for FY2024, which is N/A changed from last year.
- As of Q3 2025, HCW Biologics' Total Debt stood at $6.8 million, which was up 736.41% from $6.4 million recorded in Q2 2025.
- In the past 5 years, HCW Biologics' Total Debt ranged from a high of $38.3 million in Q4 2022 and a low of $67979.0 during Q1 2023
- In the last 4 years, HCW Biologics' Total Debt had a median value of $6.2 million in 2025 and averaged $6.4 million.
- Per our database at Business Quant, HCW Biologics' Total Debt soared by 528792.57% in 2024 and then skyrocketed by 736.41% in 2025.
- HCW Biologics' Total Debt (Quarter) stood at $38.3 million in 2022, then crashed by 99.69% to $117680.0 in 2023, then skyrocketed by 5265.98% to $6.3 million in 2024, then rose by 7.8% to $6.8 million in 2025.
- Its last three reported values are $6.8 million in Q3 2025, $6.4 million for Q2 2025, and $6.2 million during Q1 2025.